anemic chronic kidney disease

Kidney
Biotech

Genexine's anemia drug matches Roche-CSL product in phase 3

The investigational chronic kidney disease drug candidate matched Roche and CSL Vifor’s Mircera in an interim look at phase 3 data.
Nick Paul Taylor Apr 11, 2023 8:05am
red tape pause delay countdown FDA cancel stop

Akebia says FDA staffing issues are delaying appeal process

Feb 21, 2023 10:45am